CN113368229A - 一种接种疫苗的方法 - Google Patents
一种接种疫苗的方法 Download PDFInfo
- Publication number
- CN113368229A CN113368229A CN202110722924.2A CN202110722924A CN113368229A CN 113368229 A CN113368229 A CN 113368229A CN 202110722924 A CN202110722924 A CN 202110722924A CN 113368229 A CN113368229 A CN 113368229A
- Authority
- CN
- China
- Prior art keywords
- vaccination
- vaccine
- time
- attenuated
- inoculated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 229940031551 inactivated vaccine Drugs 0.000 claims abstract description 11
- 229940031567 attenuated vaccine Drugs 0.000 claims abstract description 9
- 238000002255 vaccination Methods 0.000 abstract description 13
- 241000700605 Viruses Species 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 229940124724 hepatitis-A vaccine Drugs 0.000 description 1
- 229940038490 inactivated hepatitis a vaccine Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
一种接种疫苗的方法，其特征在于，包括：接种者先接种灭活疫苗；接种灭活疫苗之后3天到60天的范围内接种减毒疫苗。本发明通过将疫苗接种过程分成两次接种，第一次接种灭活疫苗，第二次接种减毒疫苗，通过第一次接种灭活疫苗来大概率一段时间内提高接种者对某种病毒或细菌的抵抗力，之后再接种减毒疫苗。
Description
技术领域
本发明涉及疫苗技术领域，具体涉及一种接种疫苗的方法。
背景技术
有的时候会遇到传播性强和致病性强的病毒或传染病，很可能很短时间无法得到最合适的减毒疫苗。有些疫苗的减毒疫苗的毒性有可能较大，或不良反应较明显。本发明通过将疫苗接种过程分成两次接种，第一次接种灭活疫苗，第二次接种减毒疫苗，通过第一次接种灭活疫苗来大概率一段时间内提高接种者对某种病毒或细菌的抵抗力，之后再接种减毒疫苗。
发明内容
根据本公开的一个方面，一种接种疫苗的方法，其特征在于，包括：
接种者先接种灭活疫苗；
接种灭活疫苗之后3天到60天的范围内接种减毒疫苗。
具体实施方式
以下实施例用于说明本发明，但不用来限制本发明的范围。
实施例1
步骤一：接种者先接种甲肝灭活疫苗。
步骤二：接种者在接种甲肝灭活疫苗之后20天的时候接种甲肝减毒疫苗。
以上是本发明的具体实施方式，但本发明的保护范围不应局限于此。任何熟悉本领域的技术人员在本发明所揭露的技术范围内，可轻易想到的变化或替换，都应涵盖在本发明的保护范围之内，因此本发明的保护范围应以权利要求书所限定的保护范围为准。
Claims (1)
1.一种接种疫苗的方法，其特征在于，包括：
接种者先接种灭活疫苗；
接种灭活疫苗之后3天到60天的范围内接种减毒疫苗。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110722924.2A CN113368229A (zh) | 2021-06-29 | 2021-06-29 | 一种接种疫苗的方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110722924.2A CN113368229A (zh) | 2021-06-29 | 2021-06-29 | 一种接种疫苗的方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113368229A true CN113368229A (zh) | 2021-09-10 |
Family
ID=77579745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110722924.2A Pending CN113368229A (zh) | 2021-06-29 | 2021-06-29 | 一种接种疫苗的方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113368229A (zh) |
-
2021
- 2021-06-29 CN CN202110722924.2A patent/CN113368229A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Barrett et al. | Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases | |
| WO2008085147A3 (en) | Novel plant virus particles and methods of inactivation thereof | |
| JP2017511328A5 (zh) | ||
| JP2009539965A5 (zh) | ||
| MX2018015506A (es) | Vacuna contra virus de bronquitis infecciosa. | |
| WO2007007344A1 (en) | Inactivated poliomyelitis vaccine derived from sabin strain of polio virus | |
| Kozak et al. | The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development | |
| CL2008003845A1 (es) | Vacuna que comprende una emulsion, una bacterina tratada termicamente a 55-70°c por 5-10 horas, que comprende una suspension de bacterias muertas de la especie leptospira bratislava, y de 1 a 13 virus causantes de enfermedad porcina. | |
| AU2003288510A1 (en) | Immunizing fish against viral infection | |
| CN113368229A (zh) | 一种接种疫苗的方法 | |
| NO20070195L (no) | Vaksine mot HPV16 og HPV18 og minst en annen HPV-type valgt fra HPV31, 45 eller 52 | |
| WO2011134163A1 (zh) | 一种h9n2亚型禽流感灭活疫苗的制备方法及产品 | |
| CL2020002876A1 (es) | Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420) | |
| CN113350496A (zh) | 一种混合减毒疫苗的新冠肺炎疫苗 | |
| KR101507822B1 (ko) | 불활성화 일본 뇌염 바이러스 입자를 어쥬번트로서 사용하는 방법 | |
| US3397267A (en) | Method of producing rabies vaccine | |
| CN113350498A (zh) | 一种混合减毒疫苗的灭活疫苗 | |
| CN107557346B (zh) | 一株h9亚型低致病性禽流感病毒及其应用 | |
| NZ614147A (en) | Equine rhinitis vaccine | |
| NO20020615D0 (no) | Vaksine | |
| CN113350497A (zh) | 一种混合麻疹减毒疫苗的新冠肺炎疫苗 | |
| CN111018970B (zh) | 一种猪乙型脑炎病毒特异性阳性血清及其制备方法 | |
| Wang et al. | Research progress of rabies vaccine | |
| CN106771186A (zh) | 一种猪瘟基因工程亚单位疫苗效力的抗体检验方法 | |
| Zanella et al. | Avian influenza: approaches in the control of disease with inactivated vaccines in oil emulsion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210910 |